UPS
37
-3
AEP
64
3
CFG
93
-2
MSI
49
5
WY
54
-2
JPM
73
2
WMB
51
3
CCL
89
-3
RL
66
-3
WYNN
45
-3
SWK
59
-2
ICE
62
2
AZO
48
5
XEL
43
2
FCX
79
4
ROK
50
2
TXN
50
-2
MCHP
51
-7
VLO
42
2
EQT
56
6
UPS
37
-3
AEP
64
3
CFG
93
-2
MSI
49
5
WY
54
-2
JPM
73
2
WMB
51
3
CCL
89
-3
RL
66
-3
WYNN
45
-3
SWK
59
-2
ICE
62
2
AZO
48
5
XEL
43
2
FCX
79
4
ROK
50
2
TXN
50
-2
MCHP
51
-7
VLO
42
2
EQT
56
6
Financhill
Back

ProShares Ultra Financials Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Buy
82

UYG
ProShares Ultra Financials

Last Price:
$103.82
Seasonality Move:
2.03%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$42.83
Seasonality Move:
0.59%
Buy
82
ProShares Ultra Financials (UYG) is a Buy

Is ProShares Ultra Financials a Buy, Sell or Hold?

  • The current ProShares Ultra Financials [UYG] share price is $103.49. The Score for UYG is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • UYG is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.81. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UYG Stock Price Chart

What is ProShares Ultra Financials's stock price today?

  • The ProShares Ultra Financials share price today is $103.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UYG is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

UYG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 22.58 Buy
Relative Strength Index (14 RSI): 68.46 Buy
Chaikin Money Flow: 15154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.56 - 100.44) Buy
Bollinger Bands (100): (92.87 - 99.29) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.79 Buy
Relative Strength Index (14 RSI): 61.76 Buy
Chaikin Money Flow: 156273 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.4 - 40.3) Buy
Bollinger Bands (100): (17.9 - 35) Buy

UYG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.21 Buy
20-day SMA: 97.66 Buy
50-day SMA: 95.14 Buy
200-day SMA: 92.15 Buy
8-day EMA: 64.37 Buy
20-day EMA: 33.42 Buy
50-day EMA: 14.97 Buy
200-day EMA: 3.97 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.78 Buy
20-day SMA: 38.2 Buy
50-day SMA: 33.84 Buy
200-day SMA: 18.39 Buy
8-day EMA: 28.27 Buy
20-day EMA: 15.3 Buy
50-day EMA: 7 Buy
200-day EMA: 1.88 Buy

ProShares Ultra Financials Earnings Growth & UYG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

ProShares Ultra Financials Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):